Chen Guangbin, Xu Chunyan, Wang Ke, Wang Zhilin, Xu Guangming, Ji Xuelei
Department of Hepatobiliary Surgery, The Second People's Hospital of Wuhu, Wuhu Hospital Affiliated to East China Normal University, Wuhu, CHN.
Department of Teaching and Research, The Second People's Hospital of Wuhu, Wuhu Hospital Affiliated to East China Normal University, Wuhu, CHN.
Cureus. 2025 Aug 1;17(8):e89211. doi: 10.7759/cureus.89211. eCollection 2025 Aug.
Narrative medicine is defined as a medical approach that utilizes the power of stories, both patients' illness narratives and healthcare providers' reflective accounts, to promote healing, foster empathy, and enhance the therapeutic relationship through close attention to the language, metaphor, and meaning embedded in illness experiences. Despite its growing importance in contemporary healthcare, comprehensive bibliometric analyses of narrative medicine research trends remain limited. This study aims to systematically map global research patterns, identify key contributors, and analyze thematic evolution in narrative medicine literature over the past two decades. We conducted a comprehensive bibliometric analysis using the Citexs platform to examine narrative medicine research published from 2004 to 2024. The PubMed database was systematically searched using Boolean search terms: "narrative medicine OR medical storytelling OR clinical narrative OR patient-centered narrative OR healthcare narrative OR personalized medicine narrative". Inclusion criteria encompassed English-language articles only. Publication trends, geographic distribution, institutional productivity, author contributions, and thematic analysis were evaluated using advanced bibliometric techniques and the BioBERT biomedical language representation model for disease entity analysis. A total of 28,029 English-language articles were identified, demonstrating exponential growth with a peak output of 5,063 articles in 2024. The United States led global research productivity with 7,933 articles (28.3%), followed by the United Kingdom (4,704 articles, 16.78%) and Italy (2,743 articles, 9.79%). The University of Toronto emerged as the most productive institution (432 publications). Keyword analysis revealed "systematic review", "COVID-19", "treatment", and "artificial intelligence" as the most frequent terms, indicating the field's responsiveness to contemporary healthcare challenges and technological integration. Disease entity analysis identified "Neoplasms" (5,282 articles), "Death" (4,948 articles), "Pain" (4,345 articles), "Inflammation" (4,338 articles), and "Depressive Disorder" (3,933 articles) as the most commonly studied conditions. This bibliometric analysis demonstrates narrative medicine's transformation from a niche concept to a mainstream healthcare approach with substantial academic recognition. The exponential publication growth reflects increasing institutional support and clinical integration of narrative approaches. Geographic concentration in developed healthcare systems suggests opportunities for global expansion, particularly in culturally diverse contexts. The emergence of artificial intelligence as a research hotspot indicates the field's adaptive capacity to incorporate technological advances while maintaining humanistic principles. The predominance of cancer, death, pain, and mental health conditions underscores narrative medicine's particular relevance in addressing complex psychosocial dimensions of patient care that traditional biomedical approaches cannot fully capture. These findings emphasize narrative medicine's critical role in humanizing modern medical practice and its essential contribution to patient-centered care delivery.
叙事医学被定义为一种医学方法,它利用故事的力量,包括患者的疾病叙事和医疗服务提供者的反思性叙述,通过密切关注疾病经历中所蕴含的语言、隐喻和意义,来促进康复、培养同理心并加强治疗关系。尽管叙事医学在当代医疗保健中日益重要,但对其研究趋势的全面文献计量分析仍然有限。本研究旨在系统地描绘全球研究模式,识别关键贡献者,并分析过去二十年叙事医学文献的主题演变。我们使用Citexs平台进行了全面的文献计量分析,以研究2004年至2024年发表的叙事医学研究。使用布尔搜索词在PubMed数据库中进行系统搜索:“叙事医学或医学叙事或临床叙事或以患者为中心的叙事或医疗保健叙事或个性化医学叙事”。纳入标准仅包括英文文章。使用先进的文献计量技术和用于疾病实体分析的BioBERT生物医学语言表示模型评估出版趋势、地理分布、机构生产力、作者贡献和主题分析。共识别出28,029篇英文文章,呈现指数增长,2024年的产出峰值为5,063篇文章。美国以7,933篇文章(28.3%)引领全球研究生产力,其次是英国(4,704篇文章,16.78%)和意大利(2,743篇文章,9.79%)。多伦多大学成为生产力最高的机构(432篇出版物)。关键词分析显示“系统评价”“COVID-19”“治疗”和“人工智能”是最常见的术语,表明该领域对当代医疗保健挑战和技术整合的响应能力。疾病实体分析确定“肿瘤”(5,282篇文章)、“死亡”(4,948篇文章)、“疼痛”(4,345篇文章)、“炎症”(4,338篇文章)和“抑郁症”(3,933篇文章)是研究最普遍的病症。这项文献计量分析表明叙事医学已从一个小众概念转变为主流医疗保健方法,并获得了大量学术认可。出版物的指数增长反映了机构支持的增加和叙事方法在临床中的整合。在发达医疗保健系统中的地理集中表明了全球扩展的机会,特别是在文化多元的背景下。人工智能作为研究热点的出现表明该领域在纳入技术进步的同时保持人文原则的适应能力。癌症、死亡、疼痛和心理健康状况的主导地位凸显了叙事医学在解决传统生物医学方法无法完全涵盖的患者护理复杂社会心理层面方面的特殊相关性。这些发现强调了叙事医学在使现代医疗实践人性化方面的关键作用及其对以患者为中心的护理提供的重要贡献。